A Phase 2 Study of 16α-[18F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)
暂无分享,去创建一个
D. Mankoff | H. Linden | J. Eary | P. Porter | L. Shankar | B. Kurland | J. Link | V. Gadi | L. Peterson | E. Schubert | J. Specht | J. Link | Hannah M. Linden